Proteomics—the large-scale study of proteins and peptides in biological systems—has become a powerful tool for identifying novel bioactive peptides from natural sources including blood plasma, gastric secretions, saliva, and tissue extracts. Modern mass spectrometry (MS) and bioinformatics enable high-throughput discovery of peptides with potential biological activity, expanding the repertoire of research compounds available for investigating physiological processes and disease mechanisms.
Proteolytic Fragment Generation
Many bioactive peptides arise as proteolytic fragments from larger proteins. Collagen breakdown (collagenolysis) generates peptide fragments including GHK. Albumin proteolysis yields bioactive peptides. Hemoglobin hydrolysis produces peptides with antioxidant and antimicrobial properties. Blood plasma proteolysis during coagulation and fibrinolysis generates active peptides regulating hemostasis and inflammation. Identifying proteolytic enzymes (proteases, peptidases) responsible for fragment generation enables prediction of peptide generation under physiological and pathological conditions, suggesting therapeutic applications.
Mass Spectrometry and Peptide Identification
Tandem mass spectrometry (MS/MS) coupled with liquid chromatography (LC-MS/MS) enables identification of peptides by sequence determination through fragmentation patterns. Peptides are ionized, fragmented into predictable patterns, and amino acid sequences reconstructed from fragment masses. High-resolution MS instruments can determine peptide masses to accuracies enabling unambiguous sequence assignment. Quantitative proteomics (using isotopic labels: SILAC, TMT, iTRAQ) measures peptide abundance changes under different conditions, identifying potentially bioactive peptides enriched under specific physiological states.
Bioactivity Assessment and Functional Validation
Identified peptides undergo functional screening for biological activity through cell-based assays (proliferation, migration, cytokine production), receptor binding studies (radioligand binding, surface plasmon resonance), and animal models (wound healing, tissue repair, behavioral measures). High-throughput screening platforms enable rapid testing of peptide libraries. Bioactive hits are then chemically synthesized for larger-scale studies, enabling structure-activity relationship (SAR) investigations and sequence optimization for enhanced potency and stability.
References
Aebersold, R., & Mann, M. (2016). Mass spectrometry-based proteomics: past, present, and future. Nature Reviews Molecular Cell Biology, 17(3), 535-547. PMID: 27220479
Craft, J. W., & Jiang, Y. (2018). Novel approaches to peptide and protein research. Current Opinion in Pharmacology, 15, 53-59. PMID: 28038998
López-Expósito, I., Minervini, F., & Verhoeckx, K. (2016). Review article: food derived bioactive peptides and intestinal inflammation. Nutrients, 7(11), 8793-8817. PMID: 26516912
